
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15035661
[patent_doc_number] => 20190328835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/063220
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063220
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063220 | Means and methods for treating copper-related diseases | Dec 15, 2016 | Issued |
Array
(
[id] => 14611551
[patent_doc_number] => 10358461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Precipitable peptides
[patent_app_type] => utility
[patent_app_number] => 15/377243
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26346
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15377243
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/377243 | Precipitable peptides | Dec 12, 2016 | Issued |
Array
(
[id] => 13604029
[patent_doc_number] => 20180353563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => NOVEL USE
[patent_app_type] => utility
[patent_app_number] => 16/060096
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060096
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060096 | Method for the treatment of skin disorders using dipeptide diaminobutyroyl benzylamide diacetate | Dec 8, 2016 | Issued |
Array
(
[id] => 13547143
[patent_doc_number] => 20180325119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 15/774690
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774690
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774690 | INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE | Dec 7, 2016 | Abandoned |
Array
(
[id] => 11662600
[patent_doc_number] => 20170151306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/371333
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26503
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15371333
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/371333 | Dosing regimens for echinocandin class compounds | Dec 6, 2016 | Issued |
Array
(
[id] => 11515565
[patent_doc_number] => 20170082636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'METHOD OF DETECTING AT LEAST ONE MECHANISM OF RESISTANCE TO CARBAPENEMS BY MASS SPECTROMETRY'
[patent_app_type] => utility
[patent_app_number] => 15/370128
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61682
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15370128
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/370128 | Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry | Dec 5, 2016 | Issued |
Array
(
[id] => 13574937
[patent_doc_number] => 20180339017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 15/774622
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774622 | Co-agonists of the glucagon and GLP-1 receptors | Dec 4, 2016 | Issued |
Array
(
[id] => 13603875
[patent_doc_number] => 20180353486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DARIER DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/780722
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780722 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DARIER DISEASE | Nov 29, 2016 | Abandoned |
Array
(
[id] => 11663567
[patent_doc_number] => 20170152286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'STAPLED HELICAL PEPTIDES AND METHODS OF SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 15/363626
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15011
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15363626
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/363626 | Stapled helical peptides and methods of synthesis | Nov 28, 2016 | Issued |
Array
(
[id] => 15395821
[patent_doc_number] => 10538554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Peptides and uses therefor as antiviral agents
[patent_app_type] => utility
[patent_app_number] => 15/778822
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 17000
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778822 | Peptides and uses therefor as antiviral agents | Nov 27, 2016 | Issued |
Array
(
[id] => 17586554
[patent_doc_number] => 11324796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Method for regulating lipolysis and fatty acid oxidative metabolism
[patent_app_type] => utility
[patent_app_number] => 16/311221
[patent_app_country] => US
[patent_app_date] => 2016-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 8652
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311221 | Method for regulating lipolysis and fatty acid oxidative metabolism | Nov 23, 2016 | Issued |
Array
(
[id] => 11995449
[patent_doc_number] => 20170299604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'SRM METHODS IN ALZHEIMER\'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 15/355213
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29149
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355213
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/355213 | SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS | Nov 17, 2016 | Abandoned |
Array
(
[id] => 11471490
[patent_doc_number] => 20170058273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'N-terminal Derivatisation of Proteins with Polysaccharides'
[patent_app_type] => utility
[patent_app_number] => 15/352466
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10389
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352466 | N-terminal derivatisation of proteins with polysaccharides | Nov 14, 2016 | Issued |
Array
(
[id] => 11471490
[patent_doc_number] => 20170058273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'N-terminal Derivatisation of Proteins with Polysaccharides'
[patent_app_type] => utility
[patent_app_number] => 15/352466
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10389
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352466
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352466 | N-terminal derivatisation of proteins with polysaccharides | Nov 14, 2016 | Issued |
Array
(
[id] => 11491503
[patent_doc_number] => 20170065688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE'
[patent_app_type] => utility
[patent_app_number] => 15/352375
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18024
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352375 | COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE | Nov 14, 2016 | Abandoned |
Array
(
[id] => 11499183
[patent_doc_number] => 20170073369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'METHODS FOR THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/346522
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13357
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15346522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/346522 | METHODS FOR THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA AND RELATED DISORDERS | Nov 7, 2016 | Abandoned |
Array
(
[id] => 12526941
[patent_doc_number] => 10005823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Peptides having effects on promoting wound healing, collagen production, angiogenesis, activation of immunocytes and applications thereof
[patent_app_type] => utility
[patent_app_number] => 15/336212
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2954
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336212
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/336212 | Peptides having effects on promoting wound healing, collagen production, angiogenesis, activation of immunocytes and applications thereof | Oct 26, 2016 | Issued |
Array
(
[id] => 13867567
[patent_doc_number] => 20190030124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => USE OF DERMCIDIN IN STERILE INFLAMMATORY CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 15/769880
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769880
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769880 | Use of dermcidin in sterile inflammatory conditions | Oct 20, 2016 | Issued |
Array
(
[id] => 11435978
[patent_doc_number] => 20170036999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'IMMUNOSTIMULATING AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/331094
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22099
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331094 | Immunostimulating agent | Oct 20, 2016 | Issued |
Array
(
[id] => 13276643
[patent_doc_number] => 10149887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
[patent_app_type] => utility
[patent_app_number] => 15/331478
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 39
[patent_no_of_words] => 31667
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331478 | Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment | Oct 20, 2016 | Issued |